PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
WW vs. NVO
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between WW and NVO is 0.15, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.0
Correlation: 0.2

Performance

WW vs. NVO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in WW International, Inc. (WW) and Novo Nordisk A/S (NVO). The values are adjusted to include any dividend payments, if applicable.

0.00%2,000.00%4,000.00%6,000.00%8,000.00%10,000.00%NovemberDecember2025FebruaryMarchApril
-99.49%
4,836.26%
WW
NVO

Key characteristics

Sharpe Ratio

WW:

-0.61

NVO:

-1.25

Sortino Ratio

WW:

-1.21

NVO:

-1.92

Omega Ratio

WW:

0.85

NVO:

0.75

Calmar Ratio

WW:

-0.92

NVO:

-0.87

Martin Ratio

WW:

-1.79

NVO:

-1.81

Ulcer Index

WW:

51.21%

NVO:

28.67%

Daily Std Dev

WW:

149.57%

NVO:

41.46%

Max Drawdown

WW:

-99.87%

NVO:

-70.96%

Current Drawdown

WW:

-99.87%

NVO:

-59.68%

Fundamentals

Market Cap

WW:

$10.42M

NVO:

$282.79B

EPS

WW:

-$4.34

NVO:

$3.42

PEG Ratio

WW:

4.92

NVO:

0.86

PS Ratio

WW:

0.01

NVO:

0.97

PB Ratio

WW:

0.00

NVO:

11.88

Total Revenue (TTM)

WW:

$576.69M

NVO:

$225.05B

Gross Profit (TTM)

WW:

$392.52M

NVO:

$190.45B

EBITDA (TTM)

WW:

$60.81M

NVO:

$113.24B

Returns By Period

In the year-to-date period, WW achieves a -89.76% return, which is significantly lower than NVO's -31.39% return. Over the past 10 years, WW has underperformed NVO with an annualized return of -33.53%, while NVO has yielded a comparatively higher 9.66% annualized return.


WW

YTD

-89.76%

1M

-77.59%

6M

-90.15%

1Y

-92.86%

5Y*

-63.51%

10Y*

-33.53%

NVO

YTD

-31.39%

1M

-25.30%

6M

-50.02%

1Y

-51.74%

5Y*

14.89%

10Y*

9.66%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

WW vs. NVO — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

WW
The Risk-Adjusted Performance Rank of WW is 1010
Overall Rank
The Sharpe Ratio Rank of WW is 2020
Sharpe Ratio Rank
The Sortino Ratio Rank of WW is 1111
Sortino Ratio Rank
The Omega Ratio Rank of WW is 1313
Omega Ratio Rank
The Calmar Ratio Rank of WW is 22
Calmar Ratio Rank
The Martin Ratio Rank of WW is 44
Martin Ratio Rank

NVO
The Risk-Adjusted Performance Rank of NVO is 33
Overall Rank
The Sharpe Ratio Rank of NVO is 11
Sharpe Ratio Rank
The Sortino Ratio Rank of NVO is 33
Sortino Ratio Rank
The Omega Ratio Rank of NVO is 44
Omega Ratio Rank
The Calmar Ratio Rank of NVO is 44
Calmar Ratio Rank
The Martin Ratio Rank of NVO is 44
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

WW vs. NVO - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for WW International, Inc. (WW) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for WW, currently valued at -0.61, compared to the broader market-2.00-1.000.001.002.003.00
WW: -0.61
NVO: -1.25
The chart of Sortino ratio for WW, currently valued at -1.21, compared to the broader market-6.00-4.00-2.000.002.004.00
WW: -1.21
NVO: -1.92
The chart of Omega ratio for WW, currently valued at 0.85, compared to the broader market0.501.001.502.00
WW: 0.85
NVO: 0.75
The chart of Calmar ratio for WW, currently valued at -0.92, compared to the broader market0.001.002.003.004.00
WW: -0.92
NVO: -0.87
The chart of Martin ratio for WW, currently valued at -1.79, compared to the broader market-5.000.005.0010.0015.0020.00
WW: -1.79
NVO: -1.81

The current WW Sharpe Ratio is -0.61, which is higher than the NVO Sharpe Ratio of -1.25. The chart below compares the historical Sharpe Ratios of WW and NVO, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.50NovemberDecember2025FebruaryMarchApril
-0.61
-1.25
WW
NVO

Dividends

WW vs. NVO - Dividend Comparison

WW has not paid dividends to shareholders, while NVO's dividend yield for the trailing twelve months is around 2.78%.


TTM20242023202220212020201920182017201620152014
WW
WW International, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
NVO
Novo Nordisk A/S
2.78%1.68%0.99%1.18%1.34%1.86%2.12%2.46%2.13%3.94%1.31%1.96%

Drawdowns

WW vs. NVO - Drawdown Comparison

The maximum WW drawdown since its inception was -99.87%, which is greater than NVO's maximum drawdown of -70.96%. Use the drawdown chart below to compare losses from any high point for WW and NVO. For additional features, visit the drawdowns tool.


-100.00%-80.00%-60.00%-40.00%-20.00%NovemberDecember2025FebruaryMarchApril
-99.87%
-59.68%
WW
NVO

Volatility

WW vs. NVO - Volatility Comparison

WW International, Inc. (WW) has a higher volatility of 95.83% compared to Novo Nordisk A/S (NVO) at 15.88%. This indicates that WW's price experiences larger fluctuations and is considered to be riskier than NVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%20.00%40.00%60.00%80.00%100.00%NovemberDecember2025FebruaryMarchApril
95.83%
15.88%
WW
NVO

Financials

WW vs. NVO - Financials Comparison

This section allows you to compare key financial metrics between WW International, Inc. and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab